• Login
    View Item 
    •   Maryland Shared Open Access Repository Home
    • ScholarWorks@UMBC
    • UMBC Interdepartmental Collections
    • UMBC Theses and Dissertations
    • View Item
    •   Maryland Shared Open Access Repository Home
    • ScholarWorks@UMBC
    • UMBC Interdepartmental Collections
    • UMBC Theses and Dissertations
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Examining the role of news coverage in the dissemination of FDA prescription drug warnings

    Thumbnail
    Files
    Abrams_umbc_0434D_11558.pdf (1.497Mb)
    Permanent Link
    http://hdl.handle.net/11603/15828
    Collections
    • UMBC Theses and Dissertations
    Metadata
    Show full item record
    Author/Creator
    Unknown author
    Date
    2016-01-01
    Type of Work
    Text
    dissertation
    Department
    School of Public Policy
    Program
    Public Policy
    Rights
    This item may be protected under Title 17 of the U.S. Copyright Law. It is made available by UMBC for non-commercial research and education. For permission to publish or reproduce, please see http://aok.lib.umbc.edu/specoll/repro.php or contact Special Collections at speccoll(at)umbc.edu
    Distribution Rights granted to UMBC by the author.
    Subjects
    consumer warnings
    drug regulation
    health
    media
    news coverage
    prescription medications
    Abstract
    This thesis explores the potential role of news media coverage about U.S. Food and Drug Administration (FDA) warnings for prescription drugs in influencing patient/prescriber behavior. It extends previous literature about the impacts of the FDA warnings on antidepressants and other medication utilization in two ways. First, previous studies did not directly consider possible impacts of news coverage of these warnings on consumer behavior. This neglect of news coverage is surprising in light of an extensive communications literature demonstrating the broad influence of such lay information transmissions on human behavior, and despite concerns that errant or incomplete news coverage frequently yields unintended consequences (e.g., stopping medications rather than better patient monitoring) of targeted FDA recommendations. Second, this study used time-series data about four FDA warnings representing distinct therapeutic treatment classes for depression, smoking addiction, asthma and allergies, and diabetes. Using a variety of statistical models, this work found very small, though significant, evidence suggesting that news coverage surrounding FDA prescription drug warnings can have subtle impacts on down-stream doctor and consumer behavior. The results of this work should be of direct interest to those concerned with the dissemination of health communication messages and other technical news relevant to consumers.


    Albin O. Kuhn Library & Gallery
    University of Maryland, Baltimore County
    1000 Hilltop Circle
    Baltimore, MD 21250
    www.umbc.edu/scholarworks

    Contact information:
    Email: scholarworks-group@umbc.edu
    Phone: 410-455-3544


    If you wish to submit a copyright complaint or withdrawal request, please email mdsoar-help@umd.edu.

     

     

    My Account

    LoginRegister

    Browse

    This CollectionBy Issue DateTitlesAuthorsSubjectsType

    Statistics

    View Usage Statistics


    Albin O. Kuhn Library & Gallery
    University of Maryland, Baltimore County
    1000 Hilltop Circle
    Baltimore, MD 21250
    www.umbc.edu/scholarworks

    Contact information:
    Email: scholarworks-group@umbc.edu
    Phone: 410-455-3544


    If you wish to submit a copyright complaint or withdrawal request, please email mdsoar-help@umd.edu.